

Day Gain | ||
Gain | ||
Market Val | ||
Costs | ||
Cash | ||
Portfolio | ||
Realized | ||
Dividend |
-
$BCRX Dick Bump just sayen.
-
$BCRX I think this is in order “IF YOUR GOING THROUGH HELL, KEEP GOING” Winston Churchill
-
$BCRX I just got off the phone with Elon Musk and he said he was thinking about and could buy both Amgen and Biocryst and move both to Mars into an out of this world manufacturing facility where they could drop ship anywhere on earth. He ended with the fact that he had the transportation already lined up…so stay tuned
-
$BCRX Repeat after me PLUS PLUS PLUS. Did you hear that?
-
$BCRX This is BS I didn’t sit through a long 35k loss to be kicked when I’m on the ground come on drop a PR with some kind of value.
-
$BCRX Where did Muscle Man John go Did he throw in the towel ?
-
$BCRX Can I look yet?
-
-
$BCRX @Private 🤙 Pound it home a bunch of these idiots continue to make a future offering an issue they need to accept what the company said 2023 or move on …get off the lot adios chow good by.
-
$BCRX This has been hard but I keep repeating to myself buy hold get broke I mean rich sorry rich rich +++
-
$BCRX NEXT OUCH!
-
$BCRX NEXT OUCH!
-
$BCRX Where in the hell is the Bud Heavy I’m gonna need it either way.
-
-
$BCRX I sure would feel better if Stonehouse would post just one PLUS in the next 36–48 hrs.
-
$BCRX Didn’t put a bandaid on yesterday did it but there’s always tomorrow I’m patiently waiting.
-
-
$BCRX -10+
-
$BCRX How do you spell remember?
-
$BCRX I don’t remember signing up for this back in 2018 I just Rembrandt buy hold and get rich or was that Bitcoin?
Date | For | Estimate | Reported | Surprise | surprise % |
---|---|---|---|---|---|
2022-05-05 | 2022-03 | -0.39 | -0.4 | -0.01 | -2.56% |
2022-02-23 | 2021-12 | -0.31 | -0.4 | -0.09 | -29.03% |
2021-11-03 | 2021-09 | -0.3 | -0.33 | -0.03 | -10.00% |
2021-08-05 | 2021-06 | -0.22 | -0.24 | -0.02 | -9.09% |
2021-05-06 | 2021-03 | -0.26 | -0.36 | -0.1 | -38.46% |
2021-02-25 | 2020-12 | -0.25 | -0.34 | -0.09 | -36.00% |
Date | Firm | Action | From | To |
---|---|---|---|---|
2022-04-18 | Barclays | Downgrade | Overweight | Equal-Weight |
2022-04-12 | RBC Capital | Upgrade | Sector Perform | |
2022-04-11 | B of A Securities | Downgrade | Buy | Neutral |
2022-04-11 | Oppenheimer | Upgrade | Outperform | |
2021-12-10 | Oppenheimer | Upgrade | Outperform | |
2021-11-04 | RBC Capital | Upgrade | Sector Perform |
Date | Name | Relation | Quantity | Description |
---|---|---|---|---|
2022-04-17 | ABERCROMBIE GEORGE B | Director | 0.00 | Sale |
2022-02-27 | ASELAGE STEPHEN J | Director | 33.16K | Stock Award(Grant) |
2022-03-06 | BABU YARLAGADDA S | Officer | 230.06K | Sale |
2022-02-27 | HEGGIE THERESA | Director | 16.23K | Stock Award(Grant) |
2022-02-27 | INGRAM ROBERT ALEXANDER | Director | 80.06K | Stock Award(Grant) |
2022-02-28 | JONES MICHAEL L. | Officer | 11.20K | Sale |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2022-03-30 | Blackrock Inc. | 14.10M | 229.30M | 7.60% |
2022-03-30 | Vanguard Group, Inc. (The) | 13.21M | 214.75M | 7.12% |
2022-03-30 | Baker Brothers Advisors, LLC | 12.71M | 206.68M | 6.85% |
2022-03-30 | FMR, LLC | 8.41M | 136.82M | 4.53% |
2022-03-30 | State Street Corporation | 7.46M | 121.34M | 4.02% |
2022-03-30 | Pictet Asset Management SA | 5.11M | 83.04M | 2.75% |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2022-01-30 | SPDR (R) Ser Tr-SPDR (R) S&P (R) Biotech ETF | 5.30M | 81.83M | 2.85% |
2021-12-30 | Vanguard Total Stock Market Index Fund | 5.11M | 70.78M | 2.75% |
2022-01-30 | iShares Russell 2000 ETF | 4.13M | 63.78M | 2.22% |
2022-02-27 | Fidelity Select Portfolios - Biotechnology | 2.85M | 47.28M | 1.53% |
2021-12-30 | Vanguard Extended Market Index Fund | 2.41M | 33.40M | 1.30% |
2021-12-30 | Artisan International Small-Mid Fund | 1.89M | 26.13M | 1.02% |
Dividend | Date |
---|---|
0 | 2014-06-11 |
0 | 2014-06-05 |
0 | 2014-05-20 |
0 | 2014-05-16 |
0 | 2014-04-02 |